Fig. 2From: Phase I, two-way, crossover study to demonstrate bioequivalence and to compare safety and tolerability of single-dose XM17 vs Gonal-f® in healthy women after follicle-stimulating hormone downregulationMean (± SD) serum concentrations of FSH (IU/L) after single sc doses of XM17 or Gonal-f® (corrected for predose FSH levels) in healthy women (linear scale)Back to article page